Investment Strategies
Japanese Equities Deserve Fresh Look

The Asia-focused asset management firm talks about the case for investors taking a new look at Japan - a market that it says is attractively valued, given current trends.
  The Japanese equity market is worth examining for its valuations,
  according to Shuntaro Takeuchi, portfolio manager, at Matthews
  Asia, the US-based asset management business focused on Asia.
  
  Why are Japanese equity valuations significantly lower
  than those for US equities?
  For the past 25 years, Japan has traded at a discount versus the
  US, both in terms of price-to-earnings and price-to-book. In the
  first 15 years of this period, the discount was justified given
  Japan’s poor return on equity (ROE) and return on invested
  capital (ROIC). For the past decade, however, the market hasn’t
  been pricing in the positive changes achieved by Japanese
  companies. ROE and ROIC of Japanese companies are now within a
  few points of other markets and, if you look at median ROIC,
  Japan was higher than the US and Europe between 2016 and 2018.
  Although Japan’s profit profile is improving, we have yet to see
  a multiple expansion. In fact, multiples have shrunk in certain
  instances - and that’s where we see opportunities.
  
  What are some secular growth drivers in Japan that might
  be underrepresented in the benchmark MSCI Japan
  Index?
  Many index-based investors are missing opportunities in small
  caps. Japan offers a unique opportunity for investors to access
  growth at a very early stage, given that there are about 70-90
  Japanese IPOs each year. 
  
  A few factors are behind this environment. Venture capital (VC)
  funding in Japan totalled $2.5 billion in 2018, approximately
  one-thirtieth of the US total. For additional context, VC funding
  in China surpassed $100 billion in 2018. Compared with the US and
  China, Japanese start-ups are practically forced to go public at
  a very early stage. IPOs in Japan are often comparable to series
  B or series C funding in the US.
  
  Additionally, the absence of mega-cap high-growth companies in
  Japan structurally supports Japanese small-cap companies, which
  could copy what successful start-ups are doing. To the contrary,
  many of the larger companies in Japan are in legacy,
  slower-growth areas, and it is the smaller growth companies that
  take market share from the larger players.
  
  What opportunities can investors find in Japan that
  aren’t available in the US, Europe or emerging
  markets?
  First, compared with Europe and emerging markets, Japan is geared
  towards technology, industrials, and, to a certain extent,
  healthcare. It has a lower exposure to interest-rate sensitive
  sectors, such as financials, energy and materials. As a result,
  investing in Japan is essentially participating in the innovation
  areas of economic activity, not the fluctuation of interest
  rates.
  
  Second, Japanese small-cap stocks are liquid compared with other
  international markets. For example, Japan’s small caps trade more
  than many of the emerging market countries as a whole, and trade
  more than all frontier markets combined. Furthermore, Japanese
  small caps as an asset class have a low correlation to the
  S&P 500 Index.
  
  Third, Japan’s benchmark index, the MSCI Japan Index, has a lower
  concentration than benchmarks for other international regions,
  which creates opportunities for active investors.
  What can other countries learn from Japan’s experience
  with an ageing population? And what investment opportunities does
  it create?
  Japan has experienced an ageing society earlier than many other
  countries and 50 per cent of lifetime healthcare costs are being
  spent after age 70. With Baby Boomers now reaching this age, we
  think companies that tackle the issue of rising healthcare costs
  is a growth area and potential investment opportunity. These
  opportunities range from pharmaceuticals that cure or prevent
  diseases, to medical devices or equipment for minimally invasive
  surgeries that enable patients to have shorter hospital stays. It
  also covers healthcare platforms that rationalise the marketing
  costs of pharmaceutical companies.
  I
  Japan is also dealing with a decline in labour population, which
  creates a need for improved labour productivity - especially in
  white collar jobs. This is an area in which many software and IT
  service companies are operating, working to improve labour
  productivity and drive profit growth.
  
  With a new prime minister in Japan, what’s on the horizon
  from a government policy perspective that might promote economic
  growth?
  We see several positive developments, including Prime Minister
  Suga’s willingness to expand fiscal stimulus to offset the
  negative consequences of COVID-19 and boost domestic consumption.
Another positive we’ve seen from the government is its policy flexibility.
  The Bank of Japan (BOJ) bought ETFs to provide market liquidity
  and has the option to buy more. How do you think the BOJ will
  manage its large ETF portfolio when it comes time to slow down
  its purchases or wind down its holdings?
  
  When the BOJ said it would double ETF purchases, a key part of
  the messaging pertained to its option to do so; it did not make
  an outright commitment to double the amount. Going forward, we
  think that the BOJ can essentially carry out stealth tapering. As
  long as fundamentals remain sound and the market reflects the
  earnings potential of Japanese corporate profits, the BOJ can
  preserve its option to buy ETFs but reduce its pace of purchases.
  This would happen before outright selling.
  
  How much would a resurgence in global trade benefit
  Japan? And how much of that benefit is driven by export-related
  earnings and profits?
  From a cyclical perspective, about 60 per cent of Japanese
  corporate profits come from the export sector. It is a
  beneficiary when global trade bottoms out and starts to improve.
  That’s one of the reasons why Japanese equity markets have
  performed well year-to-date.
  
  Structurally, growth in Japan is driven by both the export sector
  and the domestic sector. Over the past decade, there has been a
  10 percentage-point decline in share of profits from the export
  sector, which has mainly been achieved by profit growth in the
  domestic services sector. In terms of investments, the Japanese
  domestic market is still the third-largest market in the
  world.
  
  What is the case for investing in growth companies in
  Japan today?
  Now is a good time to own Japanese growth equities, in our view.
  Japan’s market is a beneficiary of the bottoming out of global
  trade and subsequent improvements. Furthermore, a constant
  decline of interest rates generally favours growth stocks due to
  increased profits and multiple expansion. As global investors
  look for strong growth profiles at attractive multiples, the
  Japanese market comes into play: Japanese companies are seeing
  profit growth but haven’t yet seen multiple expansion.